Bluebird Bio

Zynteglo

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Bluebird Bio

Zynteglo HCPCS:

J3393

HCPCS Code Descriptor:

Inj, betibeglogene autotemce

Category:

J Code

Zynteglo NDCs:

73554-3111-01

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Infusion Bag

Route of Administration:

Intravenous

Zynteglo CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

73554-3111-01

About Zynteglo:

Zynteglo is a medication manufactured by Bluebird Bio and aligned to the J Code: J3393. Zynteglo is administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J3393 Added Date:

July 1, 2024

J3393 Effective Date:

July 1, 2024

J3393 Termination Date:

HCPCS Active

Zynteglo billing and coding information can be found through Bluebird bio at the link below:
Patient assistance information for Zynteglo can be found through Bluebird Bio at the following URL: https://www.zynteglohcp.com/support
Zynteglo prescribing information can be found at the link below:
Information regarding Zynteglo’s side effect information can be found at Medline Plus.